ArticleBioMed research international2014

IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.

Gergana Stancheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.